首頁 › 卵巢癌 › 加州 › Mountain View
Mountain View, CA 的 卵巢癌 臨床試驗
19 項針對 卵巢癌 的研究正在 Mountain View（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
招募中2/3 期
- Stanford Cancer Institute Palo Alto, Palo Alto · 距離 5 英里
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Stanford Cancer Institute Palo Alto, Palo Alto · 距離 5 英里
- VA Palo Alto Health Care System, Palo Alto · 距離 5 英里
A Study of PHST001 in Advanced Solid Tumors
招募中1 期
- Stanford University School of Medicine, Palo Alto · 距離 5 英里
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
招募中觀察性研究
- Stanford University, Palo Alto · 距離 5 英里
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
招募中3 期
- Stanford Women's Cancer Center, Palo Alto · 距離 5 英里
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
招募中1 期
- Stanford University Medical Center, Stanford · 距離 5 英里
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- Stanford Cancer Institute, Stanford · 距離 5 英里
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
招募中1 期
- Stanford University, Palo Alto · 距離 5 英里
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
招募中1 期
- Stanford, Palo Alto · 距離 5 英里
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 距離 5 英里
- 還有 1 項
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
招募中2 期
- 150, Palo Alto · 距離 5 英里
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
招募中3 期
- Palo Alto Medical Foundation, Palo Alto · 距離 5 英里
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
招募中1/2 期
- Stanford University, Stanford · 距離 5 英里
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
招募中1/2 期
- Stanford Women's Cancer Center, Palo Alto · 距離 5 英里
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
招募中觀察性研究
- Stanford University School of Medicine, Stanford · 距離 5 英里
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
招募中1/2 期
- Stanford Cancer Institute, Stanford · 距離 5 英里
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
招募中3 期
- Stanford Ambulatory Surgery Center Lane Operating Room, Palo Alto · 距離 5 英里
- Stanford Women's Cancer Center, Palo Alto · 距離 5 英里
- Stanford Hospital, Palo Alto · 距離 5 英里
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
招募中2 期
- Stanford Cancer Center, Palo Alto · 距離 5 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Stanford · 距離 5 英里
其他城市的 卵巢癌 試驗
- Houston, TX89 項研究
- New York City, NY69 項研究
- Boston, MA61 項研究
- Los Angeles, CA50 項研究
- Nashville, TN49 項研究
- Arlington, VA46 項研究
- Philadelphia, PA44 項研究
- Columbus, OH39 項研究
- St. Louis, MO38 項研究
- Chicago, IL36 項研究
- San Antonio, TX31 項研究
- Cleveland, OH30 項研究
Mountain View 的其他研究
- 癌症（所有類型）40 項研究
- 乳癌26 項研究
- 轉移性癌症25 項研究
- 非小細胞肺癌21 項研究
- 急性髓系白血病19 項研究
- 自閉症譜系障礙17 項研究
- 肺癌17 項研究
- 前列腺癌15 項研究
- 心臟衰竭15 項研究
- 自閉症13 項研究
- 急性淋巴母細胞性白血病13 項研究
- 大腸直腸癌13 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。